LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 130
Healthy Volunteers: f
View:
• Patients with lung cancer between January 1, 2018 and end of the Selection Period.
• Patient is 18 years of age or older on diagnosis date.
• Patient has at least 12 months of health insurance coverage prior to the diagnosis date.
Locations
Other Locations
Canada
Research Site
RECRUITING
Calgary
Research Site
RECRUITING
Toronto
Contact Information
Primary
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Time Frame
Start Date: 2025-08-20
Estimated Completion Date: 2027-09-30
Participants
Target number of participants: 60000
Treatments
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Related Therapeutic Areas
Sponsors
Leads: AstraZeneca